Stockscreener 앱 받기
7.60
3.43%
-0.27
시간 외 거래:
7.67
0.07
+0.92%
전일 마감가:
$7.87
열려 있는:
$8
하루 거래량:
1.18M
Relative Volume:
0.93
시가총액:
$596.23M
수익:
$400.05M
순이익/손실:
$181.01M
주가수익비율:
3.6203
EPS:
2.0993
순현금흐름:
$194.58M
1주 성능:
-2.31%
1개월 성능:
-3.18%
6개월 성능:
-1.94%
1년 성능:
-33.86%
1일 변동 폭
$7.58
$8.12
1주일 범위
$7.58
$8.21
52주 변동 폭
$6.125
$14.96
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
7.60 | 617.42M | 400.05M | 181.01M | 194.58M | 2.0993 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2025-06-30 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Leerink Partners | Outperform |
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2024-08-26 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
CorMedix Inc (CRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CRMD|CorMedix Inc|Price:8.020|Chg%:+0.150 - TradingKey
CorMedix Inc (CRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
ETFs Investing in CorMedix Inc. Stocks - TradingView
CRMD|CorMedix Inc|Price:7.870|Chg%:-0.180 - TradingKey
CorMedix Inc. Revenue Breakdown – LS:A2PF3G - TradingView
CorMedix Inc (CRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
CorMedix Inc. Revenue Breakdown – NASDAQ:CRMD - TradingView
(CRMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
CorMedix Inc (CRMD) Institutional Confidence - TradingKey
CRMD|CorMedix Inc|Price:8.060|Chg%:+0.010 - TradingKey
CorMedix Inc (CRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CorMedix (NASDAQ:CRMD) Stock Price Down 5.9%Time to Sell? - MarketBeat
CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
CorMedix Inc. (CRMD) Advances 1.57% as Stock Approaches Key Resistance at $8.84Money Flow - dars.gov.et
CRMD6219746 Bond Risk Profile - TradingView
CRMD6219746 Bond Coupon Profile — Rate & Payments - TradingView
CRMD6219746 Bond Profile — Key Metrics - TradingView
CRMD Stock Soared 18% Today – Here’s What Fueled CorMedix’s Triple-Digit Q1 Revenue Surge - Stocktwits
Enterprise value to revenue forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Enterprise value to revenue forward of CorMedix Inc. – LSX:A2PF3G - TradingView
Private Advisor Group LLC Buys 126,131 Shares of CorMedix Inc $CRMD - MarketBeat
RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 - Moomoo
RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating - marketscreener.com
CRMDCorMedix Inc Volatility & Greeks - Finviz
Cormedix Restructures Leadership, Expands Operating and Commercial Role - The Globe and Mail
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer - Moomoo
[8-K] CorMedix Inc. Reports Material Event - Stock Titan
Lobbying Update: $380,000 of CORMEDIX INC. lobbying was just disclosed - Quiver Quantitative
Tranche Update on CorMedix Inc.'s Equity Buyback Plan announced on February 2, 2026. - marketscreener.com
Liquidity Mapping Around (CRMD) Price Events - Stock Traders Daily
CRMD,PEP Revenue Breakdown - Finviz
CORMEDIX INC. Files 8-K: Company Details, Stock Info & SEC Filing Summary for June 25, 2026 - Minichart
CorMedix (NASDAQ: CRMD) replaces CBIZ with Ernst & Young as auditor - Stock Titan
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Yahoo Finance
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - Yahoo Finance
CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path - TradingView
CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
CorMedix Inc. (CRMD) Slips 2.74% as Stock Tests Support Near $7.25Volatility Smirk - dars.gov.et
CorMedix Inc.(NasdaqGM: CRMD) added to Russell 2000 Value Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Microcap Value Benchmark Index - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
CorMedix Inc.(NasdaqGM: CRMD) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):